Evidence map›Paper›PMID 26912443›Full record

ReviewJournal of nuclear medicine : official publication, Society of Nuclear Medicine2016

Interventional Molecular Imaging.

Stephen B Solomon, Francois Cornelis

Abstract readReview
In one paragraph

Review in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Medical Imaging Technology for Micro/Nanorobots.Nanomaterials (Basel, Switzerland) · 2023
    Review
  5. Advancements and Future Outlook of PET/CT-Guided Interventions.Techniques in vascular and interventional radiology · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Practice and prospects for PET/CT guided interventions.The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... · 2021
    Review
  10. Review
  11. Article
  12. Treatment of Primary Liver Tumors and Liver Metastases, Part 2: Non-Nuclear Medicine Techniques.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018
    Review
  13. Recent methodology advances in fluorescence molecular tomography.Visual computing for industry, biomedicine, and art · 2018
    Review
  14. Immediate PostablationJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018
    Article
  15. Long-Half-LifeJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018
    Article
  16. [Theranostics · 2018
    Article
  17. Article
  18. Article
  19. Crossing technological frontiers in radioguided intervention.European journal of nuclear medicine and molecular imaging · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stephen B SolomonDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and solomons@mskcc.org.
Francois CornelisDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and Department of Radiology, Pellegrin Hospital, Bordeaux, France.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Although molecular imaging has had a dramatic impact on diagnostic imaging, it has only recently begun to be integrated into interventional procedures. Its significant impact is attributed to its ability to provide noninvasive, physiologic information that supplements conventional morphologic imaging. The four major interventional opportunities for molecular imaging are, first, to provide guidance to localize a target; second, to provide tissue analysis to confirm that the target has been reached; third, to provide in-room, posttherapy assessment; and fourth, to deliver targeted therapeutics. With improved understanding and application of(18)F-FDG, as well as the addition of new molecular probes beyond(18)F-FDG, the future holds significant promise for the expansion of molecular imaging into the realm of interventional procedures.

Indexed as

AnimalsDrug Delivery SystemsHumansMolecular ImagingNeoplasmsNuclear MedicinePositron-Emission TomographyRadiopharmaceuticalsTomography, Emission-ComputedRadiopharmaceuticalsablationbiopsycancerfluorescence imaginginterventional oncologyinterventional radiologymolecular imagingPET/CT

Identifiers

PMID26912443
PMCPMC5484794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.